The effects of single dose anxiolytic medication on the CO2 models of anxiety: Differentiation of subjective and objective measures

Journal of Psychopharmacology

Volumn 24, Issue 5, 2010, Pages 649-656

  Papadopoulos, A ^a   Rich, A ^a   Nutt, D J ^a   Bailey, J E ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Anxiety; Anxiolytics; CO2 inhalation; Flupentixol; Hydroxyzine; Propranolol

Indexed keywords

CARBON DIOXIDE; FLUPENTIXOL; HYDROXYZINE; PLACEBO; PROPRANOLOL;

ADULT; ANXIETY; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; GENERALIZED ANXIETY DISORDER ASSESSMENT INVENTORY; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NORMAL HUMAN; PANIC SYMPTOM INVENTORY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SYSTOLIC BLOOD PRESSURE; VISUAL ANALOG SCALE;

ADMINISTRATION, INHALATION; ADULT; ANTI-ANXIETY AGENTS; ANXIETY; AROUSAL; BLOOD PRESSURE; CARBON DIOXIDE; CARDIOVASCULAR SYSTEM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FLUPENTHIXOL; HEART RATE; HUMANS; HYDROXYZINE; MALE; PROPRANOLOL; QUESTIONNAIRES; VITAL CAPACITY; YOUNG ADULT;

EID: 77952234634     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108097716     Document Type: Article

References (44)

1. Akins, VF, Bealer, SL (1993) Hypothalamic histamine release, neuro-endocrine and cardiovascular responses during tuberomammillary nucleus stimulation in the conscious rat. Neuroendocrinology 57: 849-855.
2. Argyropoulos, SV, Ploubidis, GB, Wright, TS, Palm, ME, Hood, SD, Nash, JR, et al. (2007) Development and validation of the Generalized Anxiety Disorder Inventory (GADI). J Psychopharmacol 21: 145-152.
3. Bailey, JE, Argyropoulos, SV, Lightman, SL, Nutt, DJ (2003) Does the brain noradrenaline network mediate the effects of the CO2 challenge ? J Psychopharmacol 17: 252-259.
4. Bailey, JE, Kendrick, A., Diaper, A., Potokar, JP, Nutt, DJ (2007) A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers. J Psychopharmacol 21: 42-49.
5. Bailey, JE, Papadopoulos, AP, Seddon, K., Nutt, DJ (2008) A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO2 models of experimental human anxiety. J Psychopharmacol. doi:10.1177/0269881108089603 [online- first].
6. Bailey, PL, Fung, MC, Price, RL, East, KA, Pace, NL, Goldman, MD (1990) Is there central respiratory depression after intravenous administration of propranolol ? Respiration 57: 65-69.
7. Bertani, A., Bellodi, L., Bussi, R., Caldirola, D., Cucchi, M., Perna, G. (2003) The effect of one week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: an open study. J Clin Psychopharmacol 23: 106-108.
8. Bertani, A., Caldirola, D., Bussi, R., Bellodi, L., Perna, G. (2001) The 35% CO2 hyperreactivity and clinical symptomology in patients with panic disorder after 1 week of treatment with citalopram: an open study. J Clin Psychopharmacol 21: 262-267.
9. Bertani, A., Perna, G., Arancio, C., Caldirola, D., Bellodi, L. (1997) Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study. J Clin Pharmacol 17: 97-101.
10. Coryell, W., Arndt, S. (1999) The 35% CO2 inhalation procedure: testretest reliability. Biol Psychiatry 45: 923-927.
11. Davies, SJ, Lowry, CA, Nutt, DJ (2007) Panic and hypertension: brothers in arms through 5-HT ? J Psychopharmacol 21: 563-566.
12. El-Khayat, R., Baldwin, DS (1998) Antipsychotic drugs for non-psychotic patients: assessment of the benefit/risk ratio in generalised anxiety disorder. J Psychopharmacol 12: 323-329.
13. File, SE, Lister, RG (1985) A comparison of the effects of lorazepam with those of propranolol on experimentally-induced anxiety and performance. Br J Clin Pharmacol 19: 445-451.
14. Folgering, H., Braakhekke, J. (1980) Ventilatory response to hypercapnia in normal subjects after propranolol, metoprolol and oxprenolol. Respiration 39: 139-143.
15. Gorman, JM, Browne, ST, Papp, LA, Martinez, J., Welkowitz, L., Coplan, JD, et al. (1997) Effect of antipanic treatment on response to carbon dioxide. Biol Psychiatry 42: 982-991.
16. Gorman, JM, Martinez, J., Coplan, JD, Kent, J., Kleber, M. (2004) The effect of successful treatment on the emotional and physiological response to carbon dioxide inhalation in patients with panic disorder. Biol Psychiatry 56: 862-867.
17. Head, A., Kendall, MJ, Ferner, R., Eagles, C. (1996) Acute effects of beta blockade on mood and anxiety. Br J Sports Med 30: 238-242.
18. Hidalgo, RB, Tupler, LA, Davidson, JRT (2007) An effect-size analysis of pharmacologic treatments for generalised anxiety disorder. J Psychopharmacol 21: 864-872.
19. Johnson, PL, Moratalla, R., Lightman, SL, Lowry, CA (2005) Are tuberomammillary histaminergic neurons involved in CO2-mediated arousal ? Exp Neurol 193: 228-233.
20. Jokinen, K., Koskinen, T., Selonen, R. (1984) Flupenthixol versus diazepam in the treatment of psychosomatic disorders: a double-blind, multi-centre trial in general practice. Pharmatherapeutica 3: 573-581.
21. Khan, S., Liberzon, I., Abelson, JL (2004) Effects of propranolol on symptom and endocrine responses to pentagastrin. Psychoneuroendocrinology 29: 1163-1171. (Pubitemid 38829178) (Pubitemid 38829178) (Pubitemid 38829178)
22. Kilminster, SG, Lewis, MJ, Jones, DM (1988) Anxiolytic effects of acebutolol and atenolol in healthy volunteers with induced anxiety. Psychopharmacology 95: 245-249.
23. Lader, MH, Tyrer, PJ (1972) Central and perhipheral effects of propranolol and sotalol in normal human subjects. Br J Pharmacol 45: 557-560.
24. Llorca, PM, Spadone, C., Sol, O., Danniau, A., Bougerol, T., Corruble, E., et al. (2002) Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study. J Clin Psychiatry 63: 1020-1027.
25. Mikkelsen, EJ, Detlor, J., Cohen, DJ (1981) School avoidance and social phobia triggered by haloperidol in patients with Tourettegs disorder. Am J Psychiatry 138: 1572-1576.
26. Nardi, AE, Valenca, AM, Nascimento, I., Mezzasalma, MA, Zin, WA (2000) Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks. Psychiatry Res 94: 179-184.
27. Orzechowski, RF, Currie, DS, Valancius, CA (2005) Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models. Eur J Pharmacol 506: 257-264.
28. Patrick, JM, Tutty, J., Pearson, SB (1978) Propranolol and the ventilatory response to hypoxia and hypercapnia in normal men. Clin Sci Mol Med 55: 491-497.
29. Perna, G., Bertani, A., Caldirola, D., Di Pasquale, D., Migliarese, G., Bellodi, L. (2004) Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind randomised study. J Clin Psychopharmacol 24: 277-282.
30. Perna, G., Bertani, A., Gabriele, A., Politi, E., Bellodi, L. (1997) Modification of 35% carbon dioxide hypersensitivity across one week of treatment with clomipramine and fluvoxamine: a double-blind, randomised, placebo-controlled study. J Clin Psychopharmacol 17: 173-178.
31. Pillay, NS, Stein, DJ (2007) Emerging anxiolytics. Expert Opin Emerg Drugs 12: 541-554.
32. Pols, H., Zandbergen, J., de Loof, C., Griez, E. (1991) Attenuation of carbon dioxide-induced panic after clonazepam treatment. Acta Psychiatr Scand 84: 585-586.
33. Pols, HJ, Hauzer, RC, Meijer, JA, Verburg, K., Griez, EJ (1996 b) Fluvoxamine attenuates panic induced by 35% CO2 challenge. J Clin Psychiatry 57: 539-542.
34. Pols, HJ, Verburg, K., Hauzer, R., Meijer, JA, Griez, EJ (1996 a) Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients. Biol Psychiatry 40: 913-917.
35. Poma, SZ, Milleri, S., Squassante, L., Nucci, G., Bani, M., Perini, GI, et al. (2005) Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects. J Psychopharmacol 19: 494-503.
36. Robinson, HM, Hood, SD, Bell, CJ, Nutt, DJ (2006) Dopamine and social anxiety disorder. Rev Bras Psiquiatr 28: 263-264.
37. Sanderson, WC, Wetzler, S., Asnis, GM (1994) Alprazolam blockade of CO2-provoked panic in patients with panic disorder. Am J Psychiatry 151: 1220-1222.
38. Schruers, K., Griez, E. (2004) The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder. J Psychopharmacol 18: 553-558.
39. Taylor, EA, Harrison, J., Turner, P. (1981) Propranolol in experimentally induced stress. Br J Psychiatry 139: 345-349.
40. Tyrer, P. (1976) The role of bodily feelings in anxiety. Institute of Psychiatry Maudsley Monographs 23. Ch VII The importance of bodily feelings in induced anxiety. Oxford University Press, pp. 61-85.
41. Tyrer, P. (1988) Current status of beta-blocking drugs in the treatment of anxiety disorders. Drugs 36: 773-783.
42. Van den Hout, MA, Griez, E. (1984) Panic symptoms after inhalation of carbon dioxide. Br J Psychiatry 144: 503-507.
43. Verburg, K., Pols, H., de Leeuw, M., Griez, E. (1998) Reliability of the 35% CO2 panic provocation challenge. Psychiatry Res 78: 207-214.
44. Woods, SW, Charney, DS, Loke, J., Goodman, WK, Redmond, DE, Heninger, GR (1986) Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment. Arch Gen Psychiatry 43: 900-909.